Furthermore, we explored the molecular mechanism of comorbidity between RA and cervical cancer by immunohistochemistry analysis of patients with cervical cancer combined with RA, and successfully identified three key hub genes: SPP1, LYZ, and MCM5. This evidence concerns the gene LYZ and cervical cancer.